A Novel PCNA Inhibitor with Promising Therapeutic Potential for Cancer Treatment
Topline:
The groundbreaking study unveils AOH1996, a new proliferating cell nuclear antigen (PCNA) inhibitor, as a potent anti-cancer agent with minimal side effects, offering a new avenue for cancer therapy.
